Australia TGA ARTG recordBlood gas syringe/needle, lithium heparin
Australia TGA ARTG Registered Device · Multigate Medical Devices Pty Ltd · Multigate Medical Products Pty Ltd · Class I · Started March 08, 2019
Good Name: Multigate Medical Devices Pty Ltd - Blood gas syringe/needle, lithium heparin
- Risk Class
- Class I
- Product Type
- Single Device Product
- ARTG Category
- General-Export
- Start Date
- March 08, 2019
- Effective Date
- March 08, 2019
- Country
- Australia
- Address
- 27 Llewellyn Avenue, VILLAWOOD, NSW, 2163
A syringe supplied with a needle, that contains the anticoagulant lithium heparin and is intended to be used for the collection, and preservation and/or transport, of blood for blood gas determination and/or other investigation.
Access comprehensive regulatory information for Blood gas syringe/needle, lithium heparin in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Multigate Medical Devices Pty Ltd, manufactured by Multigate Medical Products Pty Ltd in Australia. The device registration started on March 08, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.